Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
HIV Clin Trials ; 19(4): 139-147, 2018 08.
Article in English | MEDLINE | ID: mdl-30451595

ABSTRACT

The antiretroviral drug efavirenz (EFV) has been linked to disordered sleep and cognitive abnormalities. We examined sleep and cognitive function and subsequent changes following switch to an alternative integrase inhibitor-based regimen. Thirty-two HIV-infected individuals on EFV, emtricitabine, and tenofovir (EFV/FTC/TDF) without traditional risk factors for obstructive sleep apnea (OSA) were randomized 2:1 to switch to elvitegravir/cobicistat/emtricitabine/tenofovir (EVG/COBI/FTC/TDF) or to continue EFV/FTC/TDF therapy for 12 weeks. Overnight polysomnography and standardized sleep and neuropsychological assessments were performed at baseline and at 12 weeks. No significant differences in change over 12 weeks were noted between the two arms in any sleep or neuropsychological test parameter. At entry, however, the rate of sleep disordered breathing (SDB) was substantially higher in study subjects compared to published age-matched norms and resulted in a high assessed OSA rate of 59.4%. Respiratory Disturbance Index (RDI), a measure of SDB, correlated with age- and education-adjusted global neuropsychological Z-score (NPZ) (r = -0.35, p = 0.05). Sleep Maintenance Efficiency, Wake after Sleep Onset, REM Sleep and RDI correlated with domain-specific NPZ for learning and memory (all p-values ≤ 0.05). Among HIV-infected individuals on EFV-based therapy and without traditional risk factors for OSA, sleep and neuropsychological abnormalities do not readily reverse after discontinuation of EFV. High baseline rates of SDB and abnormalities in sleep architecture exist in this population correlating with neuropsychological impairment. The role of HIV immuno-virologic or lifestyle factors as contributing etiologies should be explored. OSA may be an under-recognized etiology for cognitive dysfunction during chronic HIV.


Subject(s)
Benzoxazines/adverse effects , Benzoxazines/therapeutic use , Central Nervous System Diseases/chemically induced , HIV Infections/drug therapy , HIV-1 , Sleep Wake Disorders/chemically induced , Adult , Alkynes , Anti-HIV Agents/adverse effects , Anti-HIV Agents/therapeutic use , Benzoxazines/administration & dosage , Cobicistat/administration & dosage , Cobicistat/therapeutic use , Cyclopropanes , Emtricitabine/administration & dosage , Emtricitabine/therapeutic use , Female , Humans , Male , Middle Aged , Tenofovir/administration & dosage , Tenofovir/therapeutic use
2.
Emerg Infect Dis ; 24(3): 485-491, 2018 03.
Article in English | MEDLINE | ID: mdl-29460734

ABSTRACT

Nontuberculous mycobacteria (NTM) respiratory infections represent a growing public health problem in many countries. However, there are limited published epidemiologic studies for the Western Pacific region. We reviewed respiratory specimens submitted to Diagnostic Laboratory Services in Hawaii, USA, for culture of Mycobacterium tuberculosis during August 2007-December 2011 to determine the NTM isolation rate. We observed a statistically significant increase in the rate of specimens with NTM isolated in respiratory culture (adjusted rate ratio per year 1.65, 95% CI 1.54-1.77; p<0.01). In contrast, the number of patients with respiratory cultures positive for M. tuberculosis showed no increase (adjusted rate ratio per year 0.98, 95% CI 0.94-1.01; p = 0.19). A 6-month subset of NTM isolates was identified by using a nucleic acid probe or 16S rRNA sequencing. M. avium complex and M. fortuitum were the most common NTM identified.


Subject(s)
Mycobacterium Infections, Nontuberculous/epidemiology , Mycobacterium Infections, Nontuberculous/microbiology , Nontuberculous Mycobacteria , Respiratory Tract Infections/epidemiology , Respiratory Tract Infections/microbiology , Female , Humans , Male , Mycobacterium Infections, Nontuberculous/diagnosis , Pacific Islands/epidemiology , Prevalence , Public Health Surveillance , Respiratory Tract Infections/diagnosis , United States/epidemiology
3.
Article in English | MEDLINE | ID: mdl-24110139

ABSTRACT

A design for a physiological radar monitoring system (PRMS) that can be integrated with clinical sleep monitoring systems is presented. The PRMS uses two radar systems at 2.45 GHz and 24 GHz to achieve both high sensitivity and high resolution. The system can acquire data, perform digital processing and output appropriate conventional analog outputs with a latency of 130 ms, which can be recorded and displayed by a gold standard sleep monitoring system, along with other standard sensor measurements.


Subject(s)
Monitoring, Physiologic/methods , Monitoring, Physiologic/standards , Radar , Sleep/physiology , Doppler Effect , Feasibility Studies , Humans , Polysomnography , Signal Processing, Computer-Assisted
4.
Sleep ; 32(11): 1499-506, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19928389

ABSTRACT

STUDY OBJECTIVES: Cheyne-Stokes respirations occur in 40% of patients with heart failure. Orthopnea is a cardinal symptom of heart failure and may affect the patient's sleeping angle. The objective of this study was to assess the respiratory and hemodynamic response to sleeping angle in a group of subjects with stable heart failure. DESIGN: Twenty-five patients underwent overnight polysomnography with simultaneous and continuous impedance cardiographic monitoring. Sleeping polysomnographic and impedance cardiographic data were recorded. SETTING: The study was conducted in a sleep center. PATIENTS: All 25 patients had clinically stable heart failure and left ventricular ejection fractions < 40%. INTERVENTIONS: The patients slept at 0 degrees, 15 degrees, 30 degrees, and 45 degrees in random order. MEASUREMENTS AND RESULTS: Seventeen patients had Cheyne-Stokes apneas (index > 5/h) and 23 patients had hypopneas (index > 5/h). The hypopnea index showed no response to sleeping angle. The Cheyne-Stokes apnea index decreased with increasing sleeping angle (P < 0.001). This effect was seen only during supine sleep and non-rapid eye movement sleep and was absent in non-supine sleep, rapid eye movement sleep, and during periods of wakefulness. Thoracic fluid content index and left ventricular hemodynamics measured by impedance cardiography showed no response to sleeping angle. CONCLUSIONS: Changing the heart failure patient's sleeping angle from 0 degrees to 45 degrees results in a significant decrease in Cheyne-Stokes apneas. This decrease occurs on a constant base of hypopneas. The changes in Cheyne-Stokes apneas are not related to changes in lung congestion and left ventricular hemodynamics.


Subject(s)
Cheyne-Stokes Respiration/etiology , Cheyne-Stokes Respiration/therapy , Heart Failure/complications , Heart Failure/physiopathology , Posture/physiology , Sleep/physiology , Aged , Cardiography, Impedance , Cheyne-Stokes Respiration/physiopathology , Female , Humans , Male , Middle Aged , Polysomnography , Respiratory System/physiopathology , Single-Blind Method , Stroke Volume , Treatment Outcome
5.
Respir Care ; 52(6): 755-8, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17521466

ABSTRACT

Bronchus-associated lymphoid tissue lymphoma is a rare disease. It is the most common form of primary pulmonary lymphoma but accounts for less than 1% of all non-Hodgkin's lymphomas. We describe a 67-year-old man who, despite successful treatment of active miliary tuberculosis, developed progression of a concomitant bronchus-associated lymphoid tissue lymphoma. This case is in contrast to previous reports of gastrointestinal-mucosa-associated lymphoid tissue lymphomas and bronchus-associated lymphoid tissue lymphomas, in which treatment of the precipitating antigenic stimulus lead to remission of the lymphoma.


Subject(s)
Bronchi/pathology , Lymphoid Tissue/pathology , Lymphoma , Mycobacterium tuberculosis , Aged , Humans , Lymphoma, Non-Hodgkin , Male , Radiography, Thoracic
SELECTION OF CITATIONS
SEARCH DETAIL
...